Comparative effectiveness of empiric antibiotics for community-acquired pneumonia

Pediatrics

Volumn 133, Issue 1, 2014, Pages

  Queen, Mary Ann ^a   Myers, Angela L ^a   Hall, Matthew ^b   Shah, Samir S ^c   Williams, Derek J ^d   Auger, Katherine A ^c   Jerardi, Karen E ^c   Statile, Angela M ^c   Tieder, Joel S ^e  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL ASSOCIATION   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Comparative effectiveness; Hospitalized; Pediatric; Pneumonia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILD HEALTH CARE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE EFFECTIVENESS; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEMALE; HEALTH CARE COST; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; OXYGEN THERAPY; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84891808458     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1773     Document Type: Article

References (21)

1. Lee GE, Lorch SA, Sheffler-Collins S, Kronman MP, Shah SS. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics. 2010; 126(2): 204-213
2. Keren R, Luan X, Localio R, et al Pediatric Research in Inpatient Settings (PRIS) Network. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012; 166(12): 1155-1164
3. Brogan TV, Hall M, Williams DJ, et al. Variability in processes of care and outcomes among children hospitalized with communityacquired pneumonia. Pediatr Infect Dis J. 2012;31(10): 1036-1041
4. Ambroggio L, Tabb LP, O'Meara T, Sheffler- Collins S, McGowan KL, Shah SS. Influence of antibiotic susceptibility patterns on empiric antibiotic prescribing for children hospitalized with community-acquired pneumonia. Pediatr Infect Dis J. 2012;31(4): 331-336
5. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53 (7):e25-76
6. Newman RE, Hedican EB, Herigon JC, Williams DD, Williams AR, Newland JG. Impact of a guideline on management of children hospitalized with communityacquired pneumonia. Pediatrics. 2012;129 (3). Available at: www.pediatrics.org/cgi/content/full/129/3/e597
7. Dinur-Schejter Y, Cohen-Cymberknoh M, Tenenbaum A, et al. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime. Pediatr Pulmonol. 2013;48(1): 52-58
8. Vuori-Holopainen E, Peltola H, Kallio MJ; SE-TU Study Group. Narrow- versus broadspectrum parenteral antimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime. Eur J Pediatr. 2000;159(12): 878-884
9. Williams DJ, Shah SS, Myers AL, et al. Identifying pediatric community-acquired pneumonia hospitalizations: accuracy of administrative billing codes. JAMA Pediatr. 2013;167(9): 851-858
10. Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics. 2001;107 (6). Available at: www.pediatrics.org/cgi/content/full/107/6/e99
11. Myers AL, Hall M, Williams DJ, et al. Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia. Pediatr Infect Dis J. 2013;32(7): 736-740
12. Bonafide CP, Brady PW, Keren R, Conway PH, Marsolo K, Daymont C. Development of heart and respiratory rate percentile curves for hospitalized children. Pediatrics. 2013;131(4). Available at: www.pediatrics.org/cgi/content/ full/131/4/e1150
13. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf. 2004;13(12): 841-853
14. Rosenbaum P, Rubin D. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39(1): 33-38
15. Weiss AK, Hall M, Lee GE, Kronman MP, Sheffler-Collins S, Shah SS. Adjunct corticosteroids in children hospitalized with community-acquired pneumonia. Pediatrics. 2011;127(2). Available at: www.pediatrics.org/cgi/ content/full/127/2/e255
16. Hersh AL, Shapiro DJ, Newland JG, Polgreen PM, Beekmann SE, Shah SS. Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia. PLoS ONE. 2011;6(5):e20325
17. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2): 159-177
18. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3). Available at: www.pediatrics.org/cgi/content/full/131/4/e964
19. Pérez-Trallero E, Alkorta M, Giménez MJ, Vicente D, Aguilar L. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a doseranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. J Chemother. 2001;13(2): 118-125
20. Pérez-Trallero E, Alkorta M, García-Arenzana JM, Iturzaeta A, Gomariz M. In-vitro, in-vivo and ex-vivo studies with oral betalactams against Streptococcus pneumoniae. J Antimicrob Chemother. 1998;41(6): 629-634
21. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003;37(2): 230-237